Cost-effectiveness of Different Diabetic Retinopathy Screening Modalities

Overview

Journal J Diabetes Sci Technol

Specialty Endocrinology

Date 2016 Jan 1

PMID 26719134

Citations 26

Authors

Francisco J Pasquel

Andrew M Hendrick

Martha Ryan

Emily Cason

Mohammed K Ali

K M Venkat Narayan

Affiliations

Soon will be listed here.

Abstract

Current screening strategies aimed at detection of diabetic retinopathy (DR) historically have poor compliance, but advancements in technology can enable improved access to care. Nearly 80% of all persons with diabetes live in low- and middle-income countries (LMICs), highlighting the importance of a cost effective screening program. Establishing mechanisms to reach populations with geographic and financial barriers to access is essential to prevent visual disability. Teleretinal programs leverage technology to improve access and reduce cost. The quality of currently employed screening modalities depends on many variables including the instrument used, use of pupillary mydriasis, number of photographic fields, and the qualifications of the photographer and image interpreter. Recent telemedicine and newer technological approaches have been introduced, but data for these technologies is yet limited. We present results of a systematic review of studies evaluating cost-effectiveness of DR screening, and discuss potential relevance for LMICs.

Citing Articles

Development and validation of prediction models for stroke and myocardial infarction in type 2 diabetes based on health insurance claims: does machine learning outperform traditional regression approaches?.

Stephan A, Hanselmann M, Bajramovic M, Schosser S, Laxy M Cardiovasc Diabetol. 2025; 24(1):80.

PMID: 39966813 PMC: 11837347. DOI: 10.1186/s12933-025-02640-9.

The Role of Urban Residence, Race and Ethnicity, and Glycemic Control in Receiving Standards of Care and Progression to Vision-Threatening Diabetic Retinopathy.

Varghese J, Kumar V, Bartelt J, Hendrick A, Pasquel F Diabetes Care. 2024; 48(1):29-37.

PMID: 39388377 PMC: 11695963. DOI: 10.2337/dci24-0024.

Costs and cost-effectiveness of the Kerala pilot screening programme for diabetic retinopathy in the public health system.

Wittenberg R, Anderson R, Redding S, Gopal B, Sadanandan R, Sahasranamam V Eye (Lond). 2024; 38(17):3352-3356.

PMID: 39227383 PMC: 11584660. DOI: 10.1038/s41433-024-03304-w.

Comparison of diabetic retinopathy screening between hospital-based multidisciplinary and general practice-based settings: insights from a regional study in Italy.

Olivieri C, Salato M, Campanella A, Marolo P, Parisi G, Neri G Acta Diabetol. 2024; 62(2):263-269.

PMID: 39160371 PMC: 11861431. DOI: 10.1007/s00592-024-02354-6.

Implementation Mapping of the Collaborative University of California Teleophthalmology Initiative (CUTI): A Qualitative Study Using the Exploration, Preparation, Implementation, and Sustainment (EPIS) Framework.

Radgoudarzi N, Gregg C, Quackenbush Q, Yiu G, Freeby M, Su G Cureus. 2024; 16(7):e64179.

PMID: 39119397 PMC: 11309586. DOI: 10.7759/cureus.64179.

References

Taylor-Phillips S, Mistry H, Leslie R, Todkill D, Tsertsvadze A, Connock M . Extending the diabetic retinopathy screening interval beyond 1 year: systematic review. Br J Ophthalmol. 2015; 100(1):105-14. PMC: 4717369. DOI: 10.1136/bjophthalmol-2014-305938. View

Kawasaki R, Akune Y, Hiratsuka Y, Fukuhara S, Yamada M . Cost-utility analysis of screening for diabetic retinopathy in Japan: a probabilistic Markov modeling study. Ophthalmic Epidemiol. 2014; 22(1):4-12. DOI: 10.3109/09286586.2014.988876. View

. (9) Microvascular complications and foot care. Diabetes Care. 2014; 38 Suppl:S58-66. DOI: 10.2337/dc15-S012. View

Harris M, Klein R, Cowie C, Rowland M . Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study. Diabetes Care. 1998; 21(8):1230-5. DOI: 10.2337/diacare.21.8.1230. View

. Standards of medical care in diabetes--2014. Diabetes Care. 2013; 37 Suppl 1:S14-80. DOI: 10.2337/dc14-S014. View

Khan T, Bertram M, Jina R, Mash B, Levitt N, Hofman K . Preventing diabetes blindness: cost effectiveness of a screening programme using digital non-mydriatic fundus photography for diabetic retinopathy in a primary health care setting in South Africa. Diabetes Res Clin Pract. 2013; 101(2):170-6. DOI: 10.1016/j.diabres.2013.05.006. View

Ruta L, Magliano D, Lemesurier R, Taylor H, Zimmet P, Shaw J . Prevalence of diabetic retinopathy in Type 2 diabetes in developing and developed countries. Diabet Med. 2013; 30(4):387-98. DOI: 10.1111/dme.12119. View

Klein R, Klein B, Moss S, Davis M, DeMets D . The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol. 1989; 107(2):244-9. DOI: 10.1001/archopht.1989.01070010250031. View

Haffner S, Fong D, Stern M, Pugh J, Hazuda H, PATTERSON J . Diabetic retinopathy in Mexican Americans and non-Hispanic whites. Diabetes. 1988; 37(7):878-84. DOI: 10.2337/diab.37.7.878. View

10.

Klein R, Klein B, Moss S, Davis M, DeMets D . The Wisconsin Epidemiologic Study of Diabetic Retinopathy. VI. Retinal photocoagulation. Ophthalmology. 1987; 94(7):747-53. DOI: 10.1016/s0161-6420(87)33525-0. View

11.

Askew D, Crossland L, Ware R, Begg S, Cranstoun P, Mitchell P . Diabetic retinopathy screening and monitoring of early stage disease in general practice: design and methods. Contemp Clin Trials. 2012; 33(5):969-75. DOI: 10.1016/j.cct.2012.04.011. View

12.

Prescott G, Sharp P, Goatman K, Scotland G, Fleming A, Philip S . Improving the cost-effectiveness of photographic screening for diabetic macular oedema: a prospective, multi-centre, UK study. Br J Ophthalmol. 2014; 98(8):1042-9. DOI: 10.1136/bjophthalmol-2013-304338. View

13.

Ryan M, Rajalakshmi R, Prathiba V, Anjana R, Ranjani H, Narayan K . Comparison Among Methods of Retinopathy Assessment (CAMRA) Study: Smartphone, Nonmydriatic, and Mydriatic Photography. Ophthalmology. 2015; 122(10):2038-43. PMC: 4581972. DOI: 10.1016/j.ophtha.2015.06.011. View

14.

Bursell S, Brazionis L, Jenkins A . Telemedicine and ocular health in diabetes mellitus. Clin Exp Optom. 2012; 95(3):311-27. DOI: 10.1111/j.1444-0938.2012.00746.x. View

15.

Resnikoff S, Pascolini D, Etyaale D, Kocur I, Pararajasegaram R, Pokharel G . Global data on visual impairment in the year 2002. Bull World Health Organ. 2005; 82(11):844-51. PMC: 2623053. DOI: /S0042-96862004001100009. View

16.

Kumar S, Wang E, Pokabla M, Noecker R . Teleophthalmology assessment of diabetic retinopathy fundus images: smartphone versus standard office computer workstation. Telemed J E Health. 2012; 18(2):158-62. DOI: 10.1089/tmj.2011.0089. View

17.

James M, Turner D, Broadbent D, Vora J, Harding S . Cost effectiveness analysis of screening for sight threatening diabetic eye disease. BMJ. 2000; 320(7250):1627-31. PMC: 27406. DOI: 10.1136/bmj.320.7250.1627. View

18.

Echouffo-Tcheugui J, Ali M, Roglic G, Hayward R, Narayan K . Screening intervals for diabetic retinopathy and incidence of visual loss: a systematic review. Diabet Med. 2013; 30(11):1272-92. DOI: 10.1111/dme.12274. View

19.

Rein D, Wittenborn J, Zhang X, Allaire B, Song M, Klein R . The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy. Health Serv Res. 2011; 46(5):1534-61. PMC: 3166398. DOI: 10.1111/j.1475-6773.2011.01263.x. View

20.

Bjorvig S, Johansen M, Fossen K . An economic analysis of screening for diabetic retinopathy. J Telemed Telecare. 2002; 8(1):32-5. DOI: 10.1258/1357633021937433. View